share

1,3-Bis[(4-Phenyl-1-Piperazinyl)Methyl]-7-Methyl-2-Phenylindolizine CAS NO 58892-67-4


Unit Price:

CAS No.:58892-67-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

1,3-Bis[(4-Phenyl-1-Piperazinyl)Methyl]-7-Methyl-2-Phenylindolizine CAS NO 58892-67-4 is a complex, multi-functional heterocyclic compound featuring indolizine and phenylpiperazine moieties. This specialized chemical is valued for its unique molecular architecture, which makes it a critical intermediate in advanced pharmaceutical research and fine chemical synthesis. It is primarily sought by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and advanced materials sectors for developing novel active ingredients and functional molecules.

Application

  • Pharmaceutical Intermediate: Serves as a key building block in the research and synthesis of novel drug candidates, particularly those targeting neurological and receptor-based pathways.
  • Chemical Research & Development: Used as a sophisticated scaffold in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization.
  • Agrochemical Synthesis: Acts as a precursor in the development of new-generation crop protection agents and pesticides.
  • Ligand & Catalyst Development: Employed in the creation of complex ligands for catalytic systems and metal-organic frameworks (MOFs).
  • Academic & Institutional Research: Utilized in universities and research institutes for fundamental studies in organic chemistry and heterocyclic compound behavior.
  • Fine Chemical Production: Incorporated into the multi-step synthesis of high-value, low-volume specialty chemicals.

Basic Information

Product Name 1,3-Bis[(4-Phenyl-1-Piperazinyl)Methyl]-7-Methyl-2-Phenylindolizine
CAS No. 58892-67-4
Molecular Formula C38H41N5
Molecular Weight 567.77 g/mol
Synonyms 1,3-Bis[(4-phenyl-1-piperazinyl)methyl]-7-methyl-2-phenylindolizine; 7-Methyl-2-phenyl-1,3-bis[(4-phenyl-1-piperazinyl)methyl]indolizine; 1,3-Bis(4-phenylpiperazin-1-ylmethyl)-7-methyl-2-phenylindolizine; 58892-67-4; UNII-8I4F8J29QN; 8I4F8J29QN; SCHEMBL2184225; DTXSID90423979; BCP23863; 1,3-Bis[(4-phenyl-1-piperazinyl)methyl]-7-methyl-2-phenyl-indolizine
EINECS Contact for details

Quality Control

Every batch of 1,3-Bis[(4-Phenyl-1-Piperazinyl)Methyl]-7-Methyl-2-Phenylindolizine is manufactured under controlled conditions and undergoes rigorous analytical testing to ensure identity, purity, and consistency. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates. A comprehensive Certificate of Analysis (COA) is provided with each shipment, detailing results for assay, related substances, and other critical parameters as per client requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed under an inert atmosphere (e.g., nitrogen or argon) to prevent oxidation and moisture absorption. Keep away from heat, sparks, and open flame.

Specification

Item Specification
Appearance Off-white to light yellow crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥ 97.0%
Related Substances (HPLC) Total impurities ≤ 3.0% Any single unknown impurity ≤ 1.0%
Loss on Drying ≤ 1.0%
Residue on Ignition ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.